After 400% Surge, Should Investors Care About Monte Rosa Insider Sale?
A biotech stock sprinted 400% in a year, and an insider sale worth about $882k followed. The question for investors: ...
Understand the key signals that trigger rebalancing in retirement portfolios to act promptly and protect objectives.
13,093 articlesA biotech stock sprinted 400% in a year, and an insider sale worth about $882k followed. The question for investors: ...
Meta wants cloud could shake up the cloud market and test Amazon's AWS dominance. This guide breaks down what that co...
A notable bounce in advanced micro devices stock drew attention from traders and long-term investors alike. This guid...
A sharp drop in a leveraged semiconductor ETF highlights the hidden risks of 3x bets. Learn what happened, why it mat...
As AI reshapes tech investing, two groups rise: hyperscaler stocks and AI infrastructure stocks. Learn how they inter...
When a CEO buys thousands of shares, investors take note. This article breaks down the 74,000-share purchase by Energ...
Bitcoin steadied near the $60,000 level as tensions in the Strait of Hormuz pushed oil higher and equity futures retr...
Value investing meets AI: compare Microsoft and NVIDIA to see which better value stock fits a careful, long-term appr...
Nvidia investors should watch TSMC's latest results closely. When the world’s largest chipmaker signals stronger dema...
A rare public reversal from Elon Musk shines a light on Anthropic as a leading AI player. For Amazon and Alphabet inv...
Apple stock hits all-time high as Services expand and AI bets mature. This guide breaks down current momentum, valuat...
A major fund recently added a sizable Mosaic position, highlighting growing interest in fertilizer stocks as potash p...